{"id":"W3124129499","doi":"10.1200/jco.2021.39.3_suppl.tps352","title":"A phase IIb, open-label, single-arm study of zanidatamab (ZW25) monotherapy in subjects with advanced or metastatic HER2-amplified biliary tract cancers.","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cholangiocarcinoma and Gallbladder Cancer Studies","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"ca_institutions":"Zymeworks (Canada)","funders":"","keywords":"Medicine; Gemcitabine; Response Evaluation Criteria in Solid Tumors; Gallbladder cancer; Internal medicine; Oncology; Clinical endpoint; Trastuzumab; Discontinuation; Immunohistochemistry; Gallbladder; Phases of clinical research; Regimen; Cancer; Chemotherapy; Clinical trial; Breast cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001468923,0.002003458,0.001742069,0.0005096246,0.0004937012,0.0009218722,0.0008652454,0.00140917,0.005566632],"category_scores_gemma":[0.0007770205,0.0007938698,0.001265113,0.0003870652,0.0008578235,0.000957049,0.0003079256,0.002401463,0.001571137],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00111054,"about_ca_system_score_gemma":0.001826176,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001492566,"about_ca_topic_score_gemma":0.004089771,"domain_scores_codex":[0.999653,0.000137151,0.00001880834,0.00007212241,0.0000308566,0.0000880386],"domain_scores_gemma":[0.9994826,0.00004511069,0.0001083016,0.00003759343,0.00004003456,0.0002863239],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.8529613,0.05788819,0.004674452,0.0006757283,0.001463698,0.0002375289,0.0002422553,0.001095376,0.03311797,0.000276151,0.0046554,0.04271198],"study_design_scores_gemma":[0.6860856,0.2986405,0.009114468,0.00002649966,0.0005569028,0.0001906464,0.00007329969,0.0006134862,0.001704106,0.0002251597,0.002741406,0.00002783536],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9843307,0.002485792,0.0008519093,0.000532121,0.0001917657,0.006176268,0.002170021,0.0001726757,0.003088769],"genre_scores_gemma":[0.9816264,0.001903848,0.001697131,0.001299804,0.0001886485,0.0053397,0.003165708,0.00003914572,0.004739613],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005566632,"threshold_uncertainty_score":0.01862222,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2870316309922513,"score_gpt":0.5130706577274244,"score_spread":0.2260390267351731,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}